Actively Recruiting
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Led by Asfendiyarov Kazakh National Medical University · Updated on 2025-07-11
6720
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
CONDITIONS
Official Title
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 69 years.
- Residents of 17 regions of Kazakhstan.
- Willingness to participate and provide informed consent.
You will not qualify if you...
- Age less than 18 years old or over 69 years old.
- Failure to provide informed consent or incomplete participation in data collection procedures.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asfendiyarov Kazakh National Medical University
Almaty, Kazakhstan, Kazakhstan, 050000
Actively Recruiting
Research Team
I
Ildar Fakhradiyev, Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here